Navigation Links
Professor Nancy Ip Joins aTyr Pharma's Scientific Advisory Board
Date:8/17/2009

technology in China and Hong Kong. With Pangu BioPharma, our subsidiary based in Hong Kong, we share Prof. Ip's goal of tapping the scientific talents and resources in China for strategic advantages in the biotechnology arena."

Prof. Ip obtained her Ph. D. in Pharmacology from Harvard Medical School before working as a senior staff scientist of Regeneron Pharmaceuticals, Inc. in New York and ultimately joining HKUST. She has published more than 200 papers with over 13,000 citations by other scientists and holds 18 patents. Editor-in-Chief of NeuroSignals, Prof. Ip also sits on the editorial boards for several international journals including Journal of Neuroscience. Her extensive list of awards includes being the first honoree in life sciences from China for the L'Oreal-UNESCO Women in Science Award, and being awarded the Scientific and Technological Prize of the Ho Leung Ho Lee Foundation. She received an honorary Doctor of Humane Sciences degree from Simmons College, as well as the Leader of the Year award in research and the Medal of Honor from the Hong Kong Government.

About aTyr Pharma

aTyr Pharma, Inc. is a biopharmaceutical company focused on the discovery of an entirely new class of biologics. aTyr Pharma's discovery engine for new biotherapeutics consists of novel proteins in the family of tRNA synthetases with cell signaling activities distinct from the protein synthesis activities commonly associated with the tRNA synthetases. These proteins are being developed as novel therapeutics to treat cancer, neurodegenerative diseases, inflammation, cardiovascular diseases and metabolic disorders.

www.atyrpharma.com


'/>"/>
SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Physics professor lauded for NSF efforts with prestigious award
2. Physics professor lauded for NSF efforts with prestigious award
3. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
4. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
5. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
6. Cambridge Major Appoints Professor John Hartwig as Scientific Advisor
7. Professor Straufs research is Nature Photonics’ cover article
8. Professor Toh-Ming Lu named fellow of the Materials Research Society
9. Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
10. Professor-turned-producer learns the movie biz
11. UCF professor develops vaccine to protect against black plague bioterror attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015  Neurotech Pharmaceuticals, Inc., announced today the ... Phase 2 clinical trial of NT-503 Encapsulated Cell ... subfoveal choroidal neovascularization secondary to age related macular ... endothelial growth factor (VEGF) receptor protein continuously produced ... landmark proof-of-concept study will evaluate NT-503 ECT as ...
(Date:9/2/2015)... , Sept. 2, 2015 Aytu BioScience, Inc. ... treatments for urological and related conditions, announced today that ... private placement convertible note financing, raising a total of ... totaling $3.175 million. Josh Disbrow ... this private placement are intended to be used to ...
(Date:9/2/2015)... TEL-AVIV, Israel , September 2, 2015 /PRNewswire/ ... BLGTY, TASE: BOLT) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, announced today ... treatment of glaucoma will be delivered at the ... of the European Society of Cataract & Refractive ...
(Date:9/2/2015)... , September 2, 2015 ... des Wettbewerbs BeHEARD von 2015 bekanntgeben zu können. ... Rare Genomics Institute. Biovista unterstützt mit ... für die Behandlung anderer Krankheiten als denen, für ... Laffoon und sein Team bei der Wylder ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2
... Wireless Beat-To-Beat Heart Monitoring and ... ... Inc.,(Nasdaq: BHRT ), announced it has entered into a ... rights to the,POCKETECG, a real-time wireless beat-to-beat, intelligent heart monitor ...
... 1 On the 25th/26th of July the first,ever ... rechts,der Isar" of the Technical University of Munich. The ... Surgery and Hand Surgery. The,operation, performed by a team ... Hohnke (senior physician for Plastic Surgery and Hand Surgery),and ...
... Constant Forex) Substantial Increase in Sales of the ... and key player in the development and,commercialization of molecular diagnostic tests for cancer, today announces,its revenue ... 30 June 2007 30 June 2008 Variation Variation euros)* ... ...
Cached Biology Technology:Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 2Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 3Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 4Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 5The First Ever Transplantation World-Wide of Entire Arms at the "Klinikum rechts der Isar" in Munich 2Confirmation of Strong Growth Over the First Half of 2008 2
(Date:8/20/2015)... Aug. 20, 2015   Sensory, Inc ., ... the user experience and security of consumer electronics ... announced that its TrulySecure™ is the ... to be FIDO Certified™. The FIDO ... with the FIDO UAF (Universal Authentication Framework) 1.0 ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas today ... contributor to the Submission Content Management webinar ... a non-profit forum. Dedicated to the Implementation of ... neutral platform for industry, vendors, health authorities, ... and work towards a standard method of ...
(Date:8/12/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is proud to announce that ... eClinical technology platform, has led the way to significant ... of 2015.   Q2 2015 and Q1 2015 were, ... contract value sold in the company,s 15 year history.  ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2
... Engineers at the University of California, Davis, have invented ... microchip fabrication. "The material itself (say, semiconductor wafers) ... Pan, professor of biomedical engineering. He and his fellow ... form a thick layer between two surfaces. Pan,s nanoglue, ...
... [Brown University] In a brief paper in the ... new, freely available Web-based program called Spliceman for predicting ... of messenger RNA, potentially leading to disease. "Spliceman ... and computes how likely these single nucleotide variants alter ...
... is available in German . ... impacts are not over yet, neither in Japan nor ... KIT established working groups that are still processing scientific ... is supporting the energy turnaround in Germany by conducting ...
Cached Biology News:Will a genetic mutation cause trouble? Ask Spliceman 21 year after Fukushima 21 year after Fukushima 3
... Clone/PAD: ZMD.473. Immunogen: Synthetic ... of the mouse junctophilin-2. Specificity: ... Reactivity: Mouse (positive controls: mouse skeletal ... tissues). Applications: Western blotting Immunohistochemistry(froz) ...
TGF-beta 2 MAb (Clone 8607)...
UCP1/2/3 (FL-307)...
ABIN-2 Polyclonal Ab 100 ug rabbit polyclonal antibody. Detects ABIN-2 in human/mouse. Tested in WB....
Biology Products: